tradingkey.logo
tradingkey.logo
Suchen

Aclarion Inc

ACONW
Zur Watchlist hinzufügen
0.023USD
-0.001-2.33%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM

mehr Informationen über Aclarion Inc Unternehmen

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Aclarion Inc Informationen

BörsenkürzelACONW
Name des UnternehmensAclarion Inc
IPO-datumApr 22, 2022
CEOMr. Brent Ness
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse8181 Arista Place
StadtBROOMFIELD
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl80021
Telefon18332752266
Websitehttps://aclarion.com/
BörsenkürzelACONW
IPO-datumApr 22, 2022
CEOMr. Brent Ness

Führungskräfte von Aclarion Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Dr. Jeff Thramann, M.D.
Dr. Jeff Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Aclarion Inc?

Die fünf größten Anteilseigner von Aclarion Inc sind: Mr. Gregory A. (Greg) Gould